Zinc‐Catalyzed Enantioselective Formal (3+2) Cycloadditions of Bicyclobutanes with Imines: Catalytic Asymmetric Synthesis of Azabicyclo[2.1.1]hexanes
Angewandte Chemie International Edition · 25.11.2024 · 63 (48)
DOI: 10.1002/anie.202406548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.10.2024. Verfasst von Feng Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemo/Biosensing and Chemometrics, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Ch…. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 148 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
The cycloaddition reaction involving bicyclo[1.1.0]butanes (BCBs) offers a versatile and efficient synthetic platform for producing C(sp 3 )‐rich rigid bridged ring scaffolds, which act as phenyl bioisosteres. However, there is a scarcity of catalytic asymmetric cycloadditions of BCBs to fulfill the need for enantioenriched saturated bicycles in drug design and development. In this study, an efficient synthesis of valuable azabicyclo[2.1.1]hexanes (aza‐BCHs) by an enantioselective zinc‐catalyzed (3+2) cycloadditions of BCBs with imines is reported. The reaction proceeds effectively with a novel type of BCB that incorporates a 2‐acyl imidazole group and a diverse array of alkynyl‐ and aryl‐substituted imines. The target aza‐BCHs, which consist of α‐chiral amine fragments and two quaternary carbon centers, are efficiently synthesized with up to 94 % and 96.5:3.5 er under mild conditions. Experimental and computational studies reveal that the reaction follows a concerted nucleophilic ring‐opening mechanism of BCBs with imines. This mechanism is distinct from previous studies on Lewis acid‐catalyzed cycloadditions of BCBs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Chemo/Biosensing and Chemometrics, Advanced Catalytic Engineering Research Center of the Ministry of Education, College of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan, 4…
- School of Physics and Chemistry, Hunan First Normal University, Changsha, 410205, P. R. China.
- Institute of Theoretical and Computational Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210093, P. R. China.
ORCID-Profile: Feng Wu, Wen-Biao Wu, Yuanjiu Xiao, Lei Tang, Heng-Xian He, Xue-Chun Yang, Ji-Jie Wang, Yuanlin Cai, Tong-Tong Xu, Jia-Hao Tao, Guoqiang Wang, Jian-Jun Feng
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- China Postdoctoral Science Foundation
Zitieren
APA
Wu, F., Wu, W. B., Xiao, Y., Li, Z., Tang, L., He, H. X., Yang, X. C., Wang, J. J., Cai, Y., Xu, T. T., Tao, J. H., Wang, G., & Feng, J. J. (2024). Zinc‐Catalyzed Enantioselective Formal (3+2) Cycloadditions of Bicyclobutanes with Imines: Catalytic Asymmetric Synthesis of Azabicyclo[2.1.1]hexanes. Angewandte Chemie International Edition, 63(48). https://doi.org/10.1002/anie.202406548
Vancouver
Wu F, Wu WB, Xiao Y, Li Z, Tang L, He HX, et al. Zinc‐Catalyzed Enantioselective Formal (3+2) Cycloadditions of Bicyclobutanes with Imines: Catalytic Asymmetric Synthesis of Azabicyclo[2.1.1]hexanes. Angewandte Chemie International Edition. 2024;63(48). doi:10.1002/anie.202406548
BibTeX
@article{Wu2024,
author = {Wu, Feng and Wu, Wen-Biao and Xiao, Yuanjiu and Li, Zhenxing and Tang, Lei and He, Heng-Xian and Yang, Xue-Chun and Wang, Ji-Jie and Cai, Yuanlin and Xu, Tong-Tong and Tao, Jia-Hao and Wang, Guoqiang and Feng, Jian-Jun},
title = {Zinc‐Catalyzed Enantioselective Formal (3+2) Cycloadditions of Bicyclobutanes with Imines: Catalytic Asymmetric Synthesis of Azabicyclo[2.1.1]hexanes},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {48},
doi = {10.1002/anie.202406548}
}
EUVIMED